Applying systems thinking to regenerative medicine [electronic resource] : proceedings of a workshop

상세정보

자료유형	단행본
서명/저자사항	Applying systems thinking to regenerative medicine: [electronic resource]: proceedings of a workshop / Siobhan Addie, Meredith Hackmann, Anna Nicholson, Lydia Teferra, Sarah H. Beachy, rapporteurs ; Forum on Regenerative Medicine, Board on Health Sciences Policy, Health and Medicine Division, The National Academies of Sciences, Engineering, and Medicine.
개인저자	Addie, Siobhan, rapporteur. Hackmann, Meredith, rapporteur. Teferra, Lydia, rapporteur. Nicholson, Anna, rapporteur. Beachy, Sarah H., rapporteur.
단체저자명	National Academies of Sciences, Engineering, and Medicine (U.S.). Forum on Regenerative Medicine.issuing body.
발행사항	Washington, DC: The National Academies Press, [2021]
형태사항	1 online resource (1 PDF file (148 pages)) : illustrations
ISBN	9780309151825 0309151821 9780309152525 0309152526 9780309154109 0309154103
서지주기	Includes bibliographical references.
내용주기	Front Matter -- 1. Introduction -- 2. Introduction to Systems Thinking Concepts -- 3. Exploring the Challenges of Critical Quality Attributes: The Role of Systems Thinking -- 4. Challenges Associated with Data Collection, Aggregation, and Sharing -- 5. Challenges and Opportunities Associated with Systems-Level Analysis and Modeling -- 6. Addressing Regenerative Medicine Manufacturing and Supply Chain Challenges with Systems-Level Approaches -- 7. Exploring Issues of Workforce Development Related to Systems Thinking -- References -- Appendix A: Workshop Agenda -- Appendix B: Speaker Biographical Sketches -- Appendix C: Statement of Task
요약	Regenerative medicine products, which are intended to repair or replace damaged cells or tissues in the body, include a range of therapeutic approaches such as cell- and gene-based therapies, engineered tissues, and non-biologic constructs. The current approach to characterizing the quality of a regenerative medicine product and the manufacturing process often involves measuring as many endpoints as possible, but this approach has proved to be inadequate and unsustainable. The Forum on Regenerative Medicine of the National Academies of Sciences, Engineering, and Medicine convened experts across disciplines for a 2-day virtual public workshop to explore systems thinking approaches and how they may be applied to support the identification of relevant quality attributes that can help in the optimization of manufacturing and streamline regulatory processes for regenerative medicine. A broad array of stakeholders, including data scientists, physical scientists, industry researchers, regulatory officials, clinicians, and patient representatives, discussed new advances in data acquisition, data analysis and theoretical frameworks, and how systems approaches can be applied to the development of regenerative medicine products that can address the unmet needs of patients. This publication summarizes the presentation and discussion of the workshop.
기금정보주기	This activity was supported by contracts between the National Academy of Sciences and Advanced Regenerative Manufacturing Institute; Akron Biotech; Alliance for Regenerative Medicine; American Society of Gene & Cell Therapy; Burroughs Wellcome Fund (Grant No. 1021433); California Institute for Regenerative Medicine; Centre for Commercialization of Regenerative Medicine; Department of Veterans Affairs (Contract No. VA26816C0051P00004); Food and Drug Administration: Office of the Commissioner and Center for Biologics Evaluation and Research (Grant No. 1R13FD006614-02); International Society for Cellular Therapy; International Society for Stem Cell Research; Johnson & Johnson; The Michael J. Fox Foundation for Parkinson's Research; National Institute of Standards and Technology; National Institutes of Health (Contract No. HHSN263201800029I; Order No. 75N98019F00847): National Center for Advancing Translational Sciences; National Eye Institute; National Heart, Lung, and Blood Institute; National Institute of Biomedical Imaging and Bioengineering; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; National Institute on Aging; The New York Stem Cell Foundation; and Sanofi (Contract No. 55630791). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
회의명	Applying Systems Thinking to Regenerative Medicine (Workshop) (2020 : Online)
일반주제명	Regenerative medicine. Tissue engineering. Regenerative Medicine --methods Regenerative Medicine Tissue Engineering Me?decine re?ge?ne?ratrice. Ge?nie tissulaire. Regenerative medicine Tissue engineering
분류기호(NLMC)	QT 110
분류기호(DDC)	571.889
언어	영어
바로가기